Neuberger Berman
Overview
Neuberger Berman Group LLC is a private, independent, employee-owned investment management firm. The firm manages equities, fixed income, private equity and hedge fund portfolios for global institutional investors, advisors and high-net-worth individuals. The firm offers financial planning, fiduciary services, and trust services.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Scipher Medicine | Jul 2026 | PIPE | Co-investor |
| Centauri Health Solutions | Jun 2026 | Private Equity | Lead |
| Cinder | May 2026 | Series B | Co-investor |
| Ayar Labs | Mar 2026 | Series E | Lead |
| Ryan, LLC | Mar 2026 | Private Equity | Lead |
Key People
Marco Cerrina Feroni
Senior Partner Neuberger Berman Renaissance
Alex Bacu
Managing Director, Associate Portfolio Manager
Antonio Serpico
Managing Director - Senior Portfolio Manager
Bart van der Made
Managing Director, Lead Portfolio Manager For EMD HC
Brooke Johnson
Managing Director, Senior Portfolio Manager
Chris Kocinski
Managing Director And Senior Portfolio Manager
Conrad Saldanha
Managing Director Portfolio Manager
David Levine
Managing Director, Portfolio Manager
David Ross
Managing Director, Portfolio Manager
Eileen Furukawa
Managing Director - Portfolio Manager
Eric Karlson
Managing Director, Portfolio Manager
Jamie Iselin
Managing Director, Portfolio Manager
Jason Tauber
Managing Director, Portfolio Manager
Joseph Rotter
Managing Director, Head Of Principal Strategies Group
Kei Okamura
Managing Director, Portfolio Manager Of Japanese Equities
Linda Joyce Ludwig
Portfolio Manager, Managing Director
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
